Suraksha Diagnostic Ltd Share Price (SURAKSHA)

Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited as a private limited company dated March 15 2005 issued by the Deputy Registrar of Companies West Bengal at Kolkata. Subsequently Company was converted into a public limited company and the name of Company was changed to Suraksha Diagnostic Limited and a fresh certificate of incorporation dated July 16 2024 was issued by the Registrar of Companies Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying out various pathological and radiological testing and medical consultation services in in East India. In addition to integrated pathology and radiology testing services it also offer omnichannel medical consultation services via online and offline modes to customers through 43 of its diagnostic centres which house 120 polyclinic chambers hosting 750 doctors. The diagnostic test menu included a 788 routine pathology tests ranging from basic biochemistry andhematology to 647 specialized pathology tests such as advanced biochemistry histopathology and molecular pathology and b 748 basic/intermediate radiology tests ranging from basic xrays ultrasonography USG and computerized tomography CT scans to 104 advanced radiology tests such as magnetic resonance imaging MRI scans and specialized CT scans.The first centre of the Company was launched at Kestopur in 2007. The second centre launched at Khardah in 2010 which increased the operating centres to 5. The Company increased the laboratories to 4 and the operating centres rose to 25 in 2016. The Company further acquired the business of Sunwell Diagnostic Private Limited in 2017. The operations to Meghalaya were expanded through a publicprivate partnership with the Government of Meghalaya in 2019. Further 2 preexisting diagnostic centres in Kolkata were acquired by the Company from Future Medical and Research Trust in 2020. And the first 3T MRI and 128 CT launched at New Town in 2023. The Company is planning the Public Issue upto 19189330 Equity Shares through Offer for Sale..

Revenue: ₹65.09Cr as on March 2025 (Q4 FY25)
Net Profit: ₹7.17Cr as on March 2025 (Q4 FY25)
Listing date: 06 Dec, 2024
Chairperson Name: Somnath Chatterjee